Cairo – Mubasher: The Board of Directors of Ibnsina Pharma has decided to purchase treasury shares from the open market.
The company stated in a disclosure to the Egyptian Exchange (EGX) today that the Board of Directors approved purchasing 1% of the company's total shares as treasury shares through the open market.
It clarified that the purchase process will be self-financed from the company's internal resources, aiming to support the company's share price on the exchange, as well as boost investor confidence in the company and its future performance, with the possibility of transferring the purchased shares to the employee incentive and reward scheme.
